Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai GenoSaber Biotech is a molecular diagnostics company headquartered in the Zhangjiang Hi-Tech Park of Shanghai, China. Founded in 2011, the company focuses on the research, development, and commercialization of high-sensitivity quantitative PCR (qPCR) assays for infectious diseases and oncology. Their core product line includes NMPA-approved diagnostic kits for the management of chronic viral infections such as HBV, HCV, and HIV, as well as screening tools for HPV and tuberculosis. GenoSaber's technology platform emphasizes high precision and sensitivity, catering to the needs of clinical laboratories and hospitals for personalized patient management. The company operates a GMP-compliant manufacturing facility to support its growing portfolio of molecular diagnostic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai GenoSaber Biotech.